Results 81 to 90 of about 2,139 (156)

Antibodies to Laminin β4 in Pemphigoid Diseases: Clinical–Laboratory Experience of a Single Central European Reference Centre

open access: yesAntibodies
Background/Objectives: Anti-p200 pemphigoid is a rare and likely underdiagnosed autoimmune blistering disorder. Laminin γ1 and laminin β4 have been implicated as potential target antigens in its pathogenesis. Recently, a novel indirect immunofluorescence
Maciej Marek Spałek   +6 more
doaj   +1 more source

Plectin, an unusual target antigen in bullous pemphigoid

open access: yes, 2001
BACKGROUND: Bullous pemphigoid (BP) is a blistering disease associated with autoantibodies directed against two components of hemidesmosomes, BP180 and BP230.
Favre, B.   +7 more
core   +1 more source

The possible and intriguing relationship between bullous pemphigoid and melanoma: speculations on significance and clinical relevance

open access: yesFrontiers in Immunology
Bullous pemphigoid (BP) is the most common autoimmune bullous disease: it most commonly affects individuals over 70 years old and impacts severely on their quality of life.
Filomena Russo   +6 more
doaj   +1 more source

Bullous Pemphigoid and Neurologic Diseases: Toward a Specific Serologic Profile?

open access: yes, 2018
BACKGROUND: The association of bullous pemphigoid (BP) and neurologic disease (ND) has been proven. OBJECTIVE: To investigate the presence of specific markers for the association between BP and ND.
Petrera M. R.   +10 more
core   +1 more source

The expression levels of IL-4 and IL-13 in the serum and blister fluid of patients with bullous pemphigoid

open access: yesPifu-xingbing zhenliaoxue zazhi
Objective To investigate the expression levels of type 2 inflammatory cytokines, IL-4 and IL-13, in the serum and blister fluid of patients with bullous pemphigoid (BP).
Yao ZHOU   +6 more
doaj   +1 more source

Autoantibody detection in bullous pemphigoid: clinical evaluation of the EUROPLUS Dermatology Mosaic

open access: yes, 2012
Bullous pemphigoid (BP) is an autoimmune blistering skin disease. Autoantibodies to BP180 and BP230 can be detected by indirect immunofluorescence (IIF) on different substrates (oesophagus, salt-split-skin, BP180-antigen dots, BP230-transfected cells ...
van Rijsingen, M.   +5 more
core   +1 more source

Effectiveness of Topical Application of Heterologous Platelet Rich Plasma (PRP) in Oral Mucous Membrane Pemphigoid. A Report of a Case

open access: yes, 2019
Mucous membrane pemphigoid (MMP) is a rare, predominantly mucosal subepithelialblistering disorder triggered by autoantibody reactivity to several basement membrane antigensincluding BP180, BP230, laminin 332, and type VII collagen [...
Bernardi   +5 more
core   +1 more source

Evaluation of BP180 and BP230 ELISA in the diagnosis of mucous membrane pemphigoid limited to the oral cavity: preliminary results

open access: yes, 2014
Objectives. Mucous Membrane Pemphigoid (MMP) is the clinical phenotype of a group of rare autoimmune blistering diseases characterized by autoantibodies directed against different structural proteins in epithelial basement membranes.
PETRUZZI, MASSIMO   +3 more
core  

Dupilumab for Drug-Induced Bullous Pemphigoid: A Case Series and Literature Review. [PDF]

open access: yesClin Cosmet Investig Dermatol
Sakpuwadol N   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy